Detailed results of colonoscopist- and investigator-blinded phase 2B trial of ECP, a good-tasting, easy-to-consume prep released 93.8% of patients treated with ECP achieved a colonoscopy rating of Excellent or Good, compared to 83.9% of those using standard prep Phase 3 study planned to initiate in Q1 2021 More ‘patient-friendly,’ palatable prep could help increase patient acceptance of colonoscopies for colorectal cancer scre
July 21, 2020
· 6 min read
